NCT00338260View on ClinicalTrials.gov

Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

PHASE3CompletedINTERVENTIONAL
Enrollment

496

Participants

Timeline

Start Date

June 30, 1995

Primary Completion Date

September 30, 2001

Study Completion Date

November 30, 2001

Conditions
Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)
Interventions
DRUG

MK0954, /Duration of Treatment : 5 Years

DRUG

Comparator : atenolol /Duration of Treatment : 5 Years

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00338260 - Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133) | Biotech Hunter | Biotech Hunter